AIMC Topic: Antilymphocyte Serum

Clear Filters Showing 1 to 3 of 3 articles

Usefulness of Delayed Introduction of Tacrolimus in Kidney Transplants Using Type-III Donors After Circulatory Death.

Transplantation proceedings Oct 29, 2018
INTRODUCTION: Our study compares 2 immunosuppressive strategies to reduce tacrolimus nephrotoxicity and its risk of acute tubular necrosis: delayed introduction of tacrolimus plus thymoglobulin vs initial tacrolimus plus basiliximab on the results of...
Humans Kidney Transplantation Retrospective Studies Female Adult Male Middle Aged Incidence Delayed Graft Function Tissue Donors Immunosuppressive Agents Graft Rejection Tacrolimus Antilymphocyte Serum Basiliximab
View on PubMed DOI

Application of Natural Language Processing and Network Analysis Techniques to Post-market Reports for the Evaluation of Dose-related Anti-Thymocyte Globulin Safety Patterns.

Applied clinical informatics Apr 26, 2017
OBJECTIVE: To evaluate the feasibility of automated dose and adverse event information retrieval in supporting the identification of safety patterns.
Humans Time Factors Dose-Response Relationship, Drug Natural Language Processing Feasibility Studies Safety Data Mining Antilymphocyte Serum Adverse Drug Reaction Reporting Systems
View on PubMed DOI

Prevalence of cytomegalovirus disease in kidney transplant patients in an intensive care unit.

Revista Brasileira de terapia intensiva Jan 1, 2017
OBJECTIVES: To define the frequency of cytomegalovirus disease among kidney transplant patients in an intensive care unit in which this complication was suspected and to identify predisposing factors and their possible impact on clinical outcome.
Humans Kidney Transplantation Retrospective Studies Intensive Care Units Female Aged Adult Male Middle Aged Prevalence Time Factors Logistic Models Immunosuppressive Agents Cytomegalovirus Cytomegalovirus Infections Polymerase Chain Reaction Antilymphocyte Serum
View on PubMed DOI
Popular Topics
Recent Journals